Data Health Partners Inc v. Teladoc Health Inc

I. Executive Summary and Procedural Information

• Parties & Counsel:
  • Plaintiff: Data Health Partners, Inc. (Delaware)
  • Defendant: Teladoc Health, Inc. (Delaware)
  • Plaintiff’s Counsel: Farnan LLP; Susman Godfrey L.L.P.
• Case Identification: 1:23-cv-00160, D. Del., 02/11/2026
• Venue Allegations: Venue is alleged to be proper in the District of Delaware because the Defendant, Teladoc Health, Inc., is a Delaware corporation and therefore a resident of the district.
• Core Dispute: Plaintiff alleges that Defendant’s Livongo diabetes management platform infringes four U.S. patents related to a technology platform for tracking goal progression and improving behavioral outcomes.
• Technical Context: The technology at issue is in the digital health domain, specifically applying principles of behavioral science to chronic condition management through data collection, automated analysis, and user feedback.
• Key Procedural History: The amended complaint follows an original complaint filed on February 13, 2023, which allegedly provided Defendant with notice of infringement for at least two of the patents-in-suit.

Case Timeline

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 11,144,554: Platform for Optimizing Goal Progression (Issued Oct. 12, 2021)

The Invention Explained

• Problem Addressed: The patent describes the challenge organizations face in tracking an individual's progress toward achieving specific goals, particularly for individuals with behavioral or other special needs Compl. ¶15 It notes that traditional electronic systems for this purpose have not improved significantly, often relying on paper charts or single-location computing systems that make it difficult to manage and share information effectively '554 Patent, col. 1:30-39
• The Patented Solution: The invention is a networked platform for tracking goal progression. An administrator establishes accounts for a "client" (the individual) and "providers" (caregivers or organizations) and assigns the client to providers '554 Patent, abstract The providers establish goals, a plan of action, and thresholds for the client '554 Patent, col. 31:41-45 The system then periodically receives and compiles data from the providers about the client's well-being and determines if the thresholds are being met, enabling providers to modify the plan of action if they are not '554 Patent, claim 1 The system automates the process of identifying when progress deviates significantly from expectations and alerting providers to intervene '554 Patent, col. 31:48-54
• Technical Importance: The technology claims to provide a generalized, data-driven software platform based on a successful behavioral health program, enabling its methods for improving goal adherence to be applied in a variety of settings Compl. ¶¶20, 22-23

Key Claims at a Glance

• The complaint asserts claims 3 and 10, both of which depend on independent claim 1 Compl. ¶33
• Essential elements of independent claim 1 include:
  • Receiving input from an administrator to establish a client account.
  • Assigning the client to one or more providers.
  • Determining, by the providers, treatment and assistance for the client, which is used to establish goals, a plan of action, and thresholds.
  • Periodically receiving updated data from the providers about the client's status or well-being.
  • Compiling the data received from the providers.
  • Determining whether the thresholds associated with the goals are being met based on the compiled data.
  • Modifying the plan of action, by the providers, in response to one or more thresholds not being met.
• The complaint does not explicitly reserve the right to assert other claims for this patent.

U.S. Patent No. 11,151,142: Platform for Optimizing Goal Progression (Issued Oct. 19, 2021)

The Invention Explained

• Problem Addressed: The patent addresses the same technical problem as the '554 Patent: the difficulty of tracking and managing goal-oriented outcomes using traditional paper-based or localized electronic systems, which are inefficient for viewing, updating, and sharing information '142 Patent, col. 1:30-39
• The Patented Solution: The invention is a method for tracking goal progression where a server-based system receives input to establish accounts for providers and clients, establishes desired outcomes (goals), and compiles performance data from the providers '142 Patent, claim 1 The core of the solution is the system's ability to automatically determine both whether goals are being met according to predefined rules and whether the compiled data varies from a "threshold to become significant," and then to automatically communicate alerts in response '142 Patent, claim 1
• Technical Importance: The technology provides a systematic, automated method for applying data-driven analysis to goal tracking, intended to improve outcomes by flagging significant deviations from expected progress for intervention Compl. ¶¶1, 23

Key Claims at a Glance

• The complaint asserts claims 6, 7, and 8, all of which depend on independent claim 1 Compl. ¶39
• Essential elements of independent claim 1 include:
  • Receiving input establishing accounts for providers serving clients.
  • Assigning clients to one or more providers.
  • Establishing desired outcomes for each client based on treatment and assistance required.
  • Compiling data associated with the client's performance of the desired outcomes.
  • Automatically determining if the desired outcomes are being met based on rules and if the compiled data varies from a threshold to become significant.
  • Automatically communicating alerts in response to the compiled data varying from the threshold to become significant.
• The complaint does not explicitly reserve the right to assert other claims for this patent.

U.S. Patent No. 11,675,791: System and Method for Tracking Progression Toward a Customized Goal

• Patent Identification: U.S. Patent No. 11,675,791, "System and Method for Tracking Progression Toward a Customized Goal," issued June 13, 2023 Compl. ¶12
• Technology Synopsis: The patent describes a system for tracking progress toward customized goals. The system establishes accounts for clients and providers, sets goals based on required treatment, receives data from providers (including via biometric devices), compiles the data, and automatically communicates alerts if the data varies from a threshold to become significant '791 Patent, abstract
• Asserted Claims: The complaint asserts independent claim 1 Compl. ¶45
• Accused Features: The complaint alleges that the Livongo diabetes management platform and Blood Glucose Meter infringe by establishing user accounts, setting customized health goals, receiving and compiling user data (including biometric data), determining if goals are met, and communicating alerts Compl. ¶¶29, 45

U.S. Patent No. 11,809,431: System and Method for Achieving Goals

• Patent Identification: U.S. Patent No. 11,809,431, "System and Method for Achieving Goals," issued November 7, 2023 Compl. ¶13
• Technology Synopsis: The patent describes a method for tracking goals by establishing client accounts, creating a baseline, setting goals and thresholds, compiling data (including weight and provider data), determining if progress meets thresholds by comparing against the baseline, and automatically communicating alerts in response to significant deviations '431 Patent, abstract
• Asserted Claims: The complaint asserts independent claim 1 Compl. ¶51
• Accused Features: The complaint alleges the Livongo platform infringes by creating user accounts, establishing health goals and baselines, compiling user data over time, comparing that data against thresholds, and generating alerts based on the comparison Compl. ¶¶29, 51

III. The Accused Instrumentality

Product Identification

• The "Livongo diabetes management platform and the Livongo Blood Glucose Meter," collectively referred to as the "Accused Products" Compl. ¶33

Functionality and Market Context

• The complaint alleges the Accused Products constitute a platform for managing chronic conditions, beginning with diabetes Compl. ¶24 The platform's alleged functionality centers on collecting real-time data from users, including biometric data from the glucometer, analyzing this data in the cloud against individualized profiles, and providing "actionable, personalized and timely recommendations" and alerts back to the user Compl. ¶¶25, 29 Compl. ¶29, fn. 13 The complaint positions the platform as a commercial success, noting Livongo was acquired by Teladoc in a transaction valuing Livongo at $18.5 billion, and that Teladoc now claims to be a "market leader[] in virtual care and applied health signals" Compl. ¶¶2, 37
  No probative visual evidence provided in complaint.

IV. Analysis of Infringement Allegations

The complaint references preliminary claim charts attached as exhibits, but these exhibits are not included in the provided filing. The following analysis is synthesized from the narrative infringement allegations in the complaint.

The core of the infringement theory is that the Accused Products embody the patented structure of collecting user data, automatically evaluating it against user-specific profiles or goals, and generating alerts or recommendations based on that evaluation Compl. ¶29

• Identified Points of Contention:
  • Scope Questions: A potential area of dispute may be whether terms from the patents' behavioral health context, such as "client," "provider," and "treatment," can be construed to read on the participants and functions in the accused chronic condition management system (e.g., "members," "coaches," and automated "guidance").
  • Technical Questions: The complaint alleges the accused platform "automatically evaluat[es]" data, which may raise the question of whether this evaluation performs the specific steps required by the claims, such as comparing data against a "threshold to become significant" or a "minimum growth line" '142 Patent, claim 1 '554 Patent, col. 20:53-57 The specific algorithms and rules used by the accused platform will be central to this inquiry.

V. Key Claim Terms for Construction

• The Term: "threshold to become significant" (from the '142 Patent family)

• Context and Importance: This term is central to the claimed invention's automated analysis and alert function. The outcome of the case may depend on whether the accused platform's analytics meet this definition, as opposed to performing a more generic data evaluation. Practitioners may focus on this term because it appears to define the trigger for the automated alerts that are a key feature of the patented system.

• Intrinsic Evidence for Interpretation:

  • Evidence for a Broader Interpretation: The specification suggests that the rules for determining significance can be set by the organization, stating "the system may determine the status automatically utilizing pre-determined rules" '142 Patent, col. 6:35-37 This could support a construction that is not limited to one specific formula.
  • Evidence for a Narrower Interpretation: The specification provides a specific example of what constitutes a "significant" data point: "If three consecutive data points are worse than the minimum growth line, the third data point may have a status identified as 'significant'" '142 Patent, col. 6:47-50 This could support a narrower construction requiring a specific, trend-based analysis over multiple data points rather than a simple, single-point threshold crossing.

• The Term: "provider"

• Context and Importance: The claims require actions by or data from a "provider." The infringement analysis will turn on whether the entities interacting with the accused platform (such as health "coaches" or even automated software components) qualify as "providers" under the patent's definition.

• Intrinsic Evidence for Interpretation:

  • Evidence for a Broader Interpretation: The specification of the parent patent defines a provider broadly as "an organization, business, group, school, facility, user, or caregiver, working toward specific goals or objectives" '142 Patent, col. 4:17-19 This language could support an argument that a health coach or other non-clinical user fits the definition.
  • Evidence for a Narrower Interpretation: The overall context of the patent background is behavioral health and "individuals with special needs" '142 Patent, col. 1:15-25, 1:31-33 A party could argue that the term "provider" should be limited by this context to entities providing formal treatment or assistance, potentially excluding health coaches or automated systems in a general wellness context.

VI. Other Allegations

• Indirect Infringement: The complaint alleges that Teladoc induces infringement by providing customers with instructions and user manuals, such as the Livongo Blood Glucose Monitoring System Owner's Manual, that allegedly direct users to operate the Accused Products in a manner that infringes the patents-in-suit Compl. ¶¶35, 41, 47, 53
• Willful Infringement: The complaint alleges pre-suit willfulness on "information and belief," based on Teladoc's status as a "market leader," its alleged knowledge that Livongo's business could be based on technology patented by others, and the public availability of the patents Compl. ¶¶37, 43, 49, 55 It also alleges ongoing willfulness based on knowledge of the patents at least as of the filing of the original complaint on February 13, 2023 (for the '554 and '142 Patents) and as of January 6, 2026 (for the '791 and '431 Patents) Compl. ¶¶35, 41, 47, 53

VII. Analyst’s Conclusion: Key Questions for the Case

• A core issue will be one of definitional scope: can key terms from the patents, which originated in a structured behavioral health context (e.g., "provider," "client"), be construed broadly enough to cover the users, coaches, and automated systems of a digital platform for managing chronic conditions like diabetes?
• A key evidentiary question will be one of technical implementation: does the accused platform's "cloud-based analytics" perform the specific, rules-based function of determining when data has crossed a "threshold to become significant," as required by the claims, or does it perform a more generic data evaluation that falls outside the claimed method? The case may turn on whether discovery reveals a functional and structural match between the patented method and the accused system's actual operation.